Trexquant Investment LP acquired a new position in Humana Inc (NYSE:HUM) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,332 shares of the insurance provider’s stock, valued at approximately $1,543,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. WFG Advisors LP grew its position in shares of Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 20 shares during the period. Acrospire Investment Management LLC bought a new stake in Humana in the 2nd quarter valued at approximately $120,000. Northwestern Mutual Wealth Management Co. lifted its stake in Humana by 139.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after acquiring an additional 325 shares in the last quarter. Fiduciary Trust Co. bought a new stake in Humana in the 2nd quarter valued at approximately $135,000. Finally, ClariVest Asset Management LLC bought a new stake in shares of Humana during the 3rd quarter worth approximately $144,000. 94.19% of the stock is owned by institutional investors.
Humana Inc (HUM) traded up $1.06 on Wednesday, reaching $253.34. The company’s stock had a trading volume of 927,700 shares, compared to its average volume of 1,384,502. Humana Inc has a fifty-two week low of $186.25 and a fifty-two week high of $264.56. The company has a market cap of $36,040.74, a price-to-earnings ratio of 21.53, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.63%. Humana’s dividend payout ratio is 12.59%.
A number of equities research analysts recently weighed in on HUM shares. Credit Suisse Group reduced their target price on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a report on Friday, November 10th. ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Jefferies Group reaffirmed a “hold” rating and issued a $257.00 price objective on shares of Humana in a research note on Friday, October 13th. Finally, BMO Capital Markets raised their price objective on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Twelve investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $255.45.
TRADEMARK VIOLATION WARNING: This story was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://stocknewstimes.com/2017/12/06/trexquant-investment-lp-takes-1-54-million-position-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.